Cargando…
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163194/ https://www.ncbi.nlm.nih.gov/pubmed/21819559 http://dx.doi.org/10.1186/1465-9921-12-103 |
_version_ | 1782210926124990464 |
---|---|
author | Mermis, Joel Gu, Haihua Xue, Bing Li, Fang Tawfik, Ossama Buch, Shilpa Bartolome, Sonja O'Brien-Ladner, Amy Dhillon, Navneet K |
author_facet | Mermis, Joel Gu, Haihua Xue, Bing Li, Fang Tawfik, Ossama Buch, Shilpa Bartolome, Sonja O'Brien-Ladner, Amy Dhillon, Navneet K |
author_sort | Mermis, Joel |
collection | PubMed |
description | BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction and related vascular injury. In this study, we explored the impact of HIV protein induced oxidative stress on production of hypoxia inducible factor (HIF)-1α and platelet-derived growth factor (PDGF), critical mediators implicated in the pathogenesis of HIV-PAH. METHODS: The lungs from 4-5 months old HIV-1 transgenic (Tg) rats were assessed for the presence of pulmonary vascular remodeling and HIF-1α/PDGF-BB expression in comparison with wild type controls. Human primary pulmonary arterial endothelial cells (HPAEC) were treated with HIV-associated proteins in the presence or absence of pretreatment with antioxidants, for 24 hrs followed by estimation of ROS levels and western blot analysis of HIF-1α or PDGF-BB. RESULTS: HIV-Tg rats, a model with marked viral protein induced vascular oxidative stress in the absence of active HIV-1 replication demonstrated significant medial thickening of pulmonary vessels and increased right ventricular mass compared to wild-type controls, with increased expression of HIF-1α and PDGF-BB in HIV-Tg rats. The up-regulation of both HIF-1α and PDGF-B chain mRNA in each HIV-Tg rat was directly correlated with an increase in right ventricular/left ventricular+septum ratio. Supporting our in-vivo findings, HPAECs treated with HIV-proteins: Tat and gp120, demonstrated increased ROS and parallel increase of PDGF-BB expression with the maximum induction observed on treatment with R5 type gp-120(CM). Pre-treatment of endothelial cells with antioxidants or transfection of cells with HIF-1α small interfering RNA resulted in abrogation of gp-120(CM )mediated induction of PDGF-BB, therefore, confirming that ROS generation and activation of HIF-1α plays critical role in gp120 mediated up-regulation of PDGF-BB. CONCLUSION: In summary, these findings indicate that viral protein induced oxidative stress results in HIF-1α dependent up-regulation of PDGF-BB and suggests the possible involvement of this pathway in the development of HIV-PAH. |
format | Online Article Text |
id | pubmed-3163194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31631942011-08-29 Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling Mermis, Joel Gu, Haihua Xue, Bing Li, Fang Tawfik, Ossama Buch, Shilpa Bartolome, Sonja O'Brien-Ladner, Amy Dhillon, Navneet K Respir Res Research BACKGROUND: Human immunodeficiency virus (HIV) infected patients are at increased risk for the development of pulmonary arterial hypertension (PAH). Recent reports have demonstrated that HIV associated viral proteins induce reactive oxygen species (ROS) with resultant endothelial cell dysfunction and related vascular injury. In this study, we explored the impact of HIV protein induced oxidative stress on production of hypoxia inducible factor (HIF)-1α and platelet-derived growth factor (PDGF), critical mediators implicated in the pathogenesis of HIV-PAH. METHODS: The lungs from 4-5 months old HIV-1 transgenic (Tg) rats were assessed for the presence of pulmonary vascular remodeling and HIF-1α/PDGF-BB expression in comparison with wild type controls. Human primary pulmonary arterial endothelial cells (HPAEC) were treated with HIV-associated proteins in the presence or absence of pretreatment with antioxidants, for 24 hrs followed by estimation of ROS levels and western blot analysis of HIF-1α or PDGF-BB. RESULTS: HIV-Tg rats, a model with marked viral protein induced vascular oxidative stress in the absence of active HIV-1 replication demonstrated significant medial thickening of pulmonary vessels and increased right ventricular mass compared to wild-type controls, with increased expression of HIF-1α and PDGF-BB in HIV-Tg rats. The up-regulation of both HIF-1α and PDGF-B chain mRNA in each HIV-Tg rat was directly correlated with an increase in right ventricular/left ventricular+septum ratio. Supporting our in-vivo findings, HPAECs treated with HIV-proteins: Tat and gp120, demonstrated increased ROS and parallel increase of PDGF-BB expression with the maximum induction observed on treatment with R5 type gp-120(CM). Pre-treatment of endothelial cells with antioxidants or transfection of cells with HIF-1α small interfering RNA resulted in abrogation of gp-120(CM )mediated induction of PDGF-BB, therefore, confirming that ROS generation and activation of HIF-1α plays critical role in gp120 mediated up-regulation of PDGF-BB. CONCLUSION: In summary, these findings indicate that viral protein induced oxidative stress results in HIF-1α dependent up-regulation of PDGF-BB and suggests the possible involvement of this pathway in the development of HIV-PAH. BioMed Central 2011 2011-08-05 /pmc/articles/PMC3163194/ /pubmed/21819559 http://dx.doi.org/10.1186/1465-9921-12-103 Text en Copyright ©2011 Mermis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Mermis, Joel Gu, Haihua Xue, Bing Li, Fang Tawfik, Ossama Buch, Shilpa Bartolome, Sonja O'Brien-Ladner, Amy Dhillon, Navneet K Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title_full | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title_fullStr | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title_full_unstemmed | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title_short | Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling |
title_sort | hypoxia-inducible factor-1 α/platelet derived growth factor axis in hiv-associated pulmonary vascular remodeling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163194/ https://www.ncbi.nlm.nih.gov/pubmed/21819559 http://dx.doi.org/10.1186/1465-9921-12-103 |
work_keys_str_mv | AT mermisjoel hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT guhaihua hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT xuebing hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT lifang hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT tawfikossama hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT buchshilpa hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT bartolomesonja hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT obrienladneramy hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling AT dhillonnavneetk hypoxiainduciblefactor1aplateletderivedgrowthfactoraxisinhivassociatedpulmonaryvascularremodeling |